Ethinylestradiol/dienogest in oral contraception (Q37731523)

22 August 2017

1 reference

title

Ethinylestradiol/dienogest in oral contraception (English)

1 reference

22 August 2017

1 reference

Ezequiel F Pérez-Campos

series ordinal

1

1 reference

22 August 2017

1 April 2010

1 reference

22 August 2017

1 reference

22 August 2017

70

1 reference

22 August 2017

6

1 reference

22 August 2017

681-689

1 reference

https://scigraph.springernature.com/pub.10.2165/11536320-000000000-00000

22 August 2017

0 references

cites work

Coagulation effects of oral contraception

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11536320-000000000-00000

Antibiotics in inflammatory bowel disease

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11536320-000000000-00000

Increased infertility with age in men and women.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11536320-000000000-00000

Modulation of ovarian function by an oral contraceptive containing 30 micrograms ethinyl estradiol in combination with 2.00 mg dienogest

21 January 2018

1 reference

12 December 2020

Effect of four oral contraceptives on thyroid hormones, adrenal and blood pressure parameters

1 reference

12 December 2020

A new low-dose monophasic combination oral contraceptive (Alesse) with levonorgestrel 100 micrograms and ethinyl estradiol 20 micrograms. North American Levonorgestrel Study Group (NALSG).

1 reference

12 December 2020

Effect of dienogest-containing oral contraceptives on lipid metabolism

1 reference

12 December 2020

Twelve years of clinical experience with an oral contraceptive containing 30 micrograms ethinyloestradiol and 150 micrograms desogestrel

1 reference

12 December 2020

Effects of two oral contraceptives on plasma levels of insulin-like growth factor I (IGF-I) and growth hormone (hGH).

1 reference

12 December 2020

The inhibitory effect of dienogest, a synthetic steroid, on the growth of human endometrial stromal cells in vitro

1 reference

12 December 2020

Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel

1 reference

12 December 2020

Effect of four different oral contraceptives on various sex hormones and serum-binding globulins

1 reference

12 December 2020

1 reference

12 December 2020

The efficacy and tolerability of Valette: a postmarketing surveillance study

1 reference

12 December 2020

Oral contraceptives and individual variability of circulating levels of ethinyl estradiol and progestins

1 reference

12 December 2020

Hemostatic system changes induced by 50 micrograms and 30 micrograms estrogen/progestogen oral contraceptives. Modification of estrogen effects by levonorgestrel

1 reference

12 December 2020

Clinical findings with the oral contraceptive combination ethinylestradiol/dienogest in Poland

1 reference

12 December 2020

Clinical experience with a modern low-dose oral contraceptive in almost 100,000 users

1 reference

12 December 2020

The behavior of cytoplasmic progesterone receptors in the cycling endometrium and the effect of hormonal contraceptives

1 reference

12 December 2020

Lipid metabolism during treatment of endometriosis with the progestin dienogest

1 reference

12 December 2020

Blood coagulation with a combination pill containing gestodene and ethinyl estradiol

1 reference

12 December 2020

Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate

1 reference

12 December 2020

Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on thyroid hormones and androgen parameters: conventional vs. extended-cycle use.

1 reference

12 December 2020

Clinical findings with the oral contraceptive combination ethinylestradiol/dienogest in the Czech Republic.

1 reference

12 December 2020

The fiction of an ideal hormonal contraceptive

1 reference

12 December 2020

The effects of Valette on skin and hair: a post-marketing surveillance study

1 reference

12 December 2020

Dienogest inhibits BrdU uptake with G0/G1 arrest in cultured endometriotic stromal cells

1 reference

12 December 2020

Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on various hemostasis parameters

1 reference

12 December 2020

Fertility after discontinuation of treatment with an oral contraceptive containing 30 microg of ethinyl estradiol and 2 mg of dienogest

1 reference

12 December 2020

Double-blind, randomized, placebo controlled study on the effects of the monophasic oral contraceptive containing 30 micrograms ethinyl estradiol and 2.00 mg dienogest on the hemostatic system

1 reference

12 December 2020

Minimizing the problem of poor compliance in adolescents. Clinical experience with a modern low-dose gestodene-containing oral contraceptive.

1 reference

12 December 2020

10.2165/11536320-000000000-00000

Identifiers

DOI

1 reference

PubMed ID

20394455

Dimensions Publication ID

22 August 2017

0 references

1 reference

PubMed ID

20394455